Conophylline inhibits non-alcoholic steatohepatitis in mice-Reference-Cited by-同舟云学术

Conophylline inhibits non-alcoholic steatohepatitis in mice

Published:2017-06-08 Issue:6 Volume:12 Page:e0178436
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Nakade Yukiomi^ORCID,Sakamoto Kazumasa,Yamauchi Taeko,Inoue Tadahisa,Kobayashi Yuji,Yamamoto Takaya,Ishii Norimitsu,Ohashi Tomohiko,Sumida Yoshio,Ito Kiyoaki,Nakao Haruhisa,Fukuzawa Yoshitaka,Umezawa Kazuo,Yoneda Masashi

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference41 articles.

1. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study;LA Adams;Am J Gastroenterol,2009

2. The epidemiology of nonalcoholic fatty liver disease: a global perspective;M Lazo;Semin Liver Dis,2008

3. Metabolic syndrome and non-alcoholic fatty liver disease;P Almeda-Valdes;Ann Hepatol,2009

4. The metabolic syndrome;RH Eckel;Lancet,2010

5. Epidemiology and natural history of NAFLD and NASH;JP Ong;Clin Liver Dis,2007

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Formononetin promotes fatty acid β-oxidation to treat non-alcoholic steatohepatitis through SIRT1/PGC-1α/PPARα pathway;Phytomedicine;2024-02

2. Fatty liver disease: Functional foods offer natural remedies;Functional Foods and Chronic Disease;2024

3. Hepatic fibrosis: Targeting peroxisome proliferator-activated receptor alpha from mechanism to medicines;Hepatology;2023-01-03

4. ACBP/DBI protein neutralization confers autophagy-dependent organ protection through inhibition of cell loss, inflammation, and fibrosis;Proceedings of the National Academy of Sciences;2022-10-03

5. Salvianolic acid B ameliorates non-alcoholic fatty liver disease by inhibiting hepatic lipid accumulation and NLRP3 inflammasome in ob/ob mice;International Immunopharmacology;2022-10